Joan Villarroya, Albert Blasco-Roset, Marta Giralt
{"title":"Autophagy in adipose tissue thermogenic function.","authors":"Joan Villarroya, Albert Blasco-Roset, Marta Giralt","doi":"10.1016/bs.ircmb.2025.10.006","DOIUrl":"10.1016/bs.ircmb.2025.10.006","url":null,"abstract":"<p><p>Brown adipose tissue (BAT) is the main site of adaptive thermogenesis, a heat-producing process essential for maintaining body temperature, especially in cold environments. While abundant in newborns, BAT is also present in adults, where it becomes activated under specific stimuli such as cold exposure or food intake. In addition, white adipose tissue (WAT) can undergo a \"browning\" process, generating beige adipocytes with thermogenic properties similar to classical brown adipocytes. BAT is highly innervated and vascularized, features that support its thermogenic function by facilitating sympathetic nervous system activation and efficient heat distribution. BAT activation increases energy expenditure and plays a protective role against obesity and metabolic disorders. A growing body of evidence highlights autophagy as a critical regulator of BAT and beige adipocyte function. During thermogenic activation, autophagy, especially mitophagy, is suppressed, promoting mitochondrial accumulation and heat production. Conversely, enhanced autophagy contributes to BAT whitening and functional decline, as seen in obesity and aging. Although the role of autophagy in thermogenesis remains unclear, modulating autophagic pathways represents a promising strategy to boost thermogenic activity and improve metabolic health. Understanding the molecular mechanisms underlying BAT plasticity and autophagic regulation could offer novel therapeutic avenues for combating obesity and related metabolic diseases.</p>","PeriodicalId":14422,"journal":{"name":"International review of cell and molecular biology","volume":"404 ","pages":"197-231"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148264348","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"IL-23 blockade: A strategy for managing pain-related inflammatory diseases.","authors":"Mario García-Domínguez","doi":"10.1016/bs.ircmb.2026.02.005","DOIUrl":"10.1016/bs.ircmb.2026.02.005","url":null,"abstract":"<p><p>IL-23, a cytokine involved in regulating immune system activity, plays an essential role in the development and progression of pain-associated inflammatory disorders. By promoting the differentiation and activation of Th17 cells, IL-23 induces the production of pro-inflammatory cytokines, including IL-17. These pro-inflammatory cytokines are key mediators of tissue damage and chronic inflammation observed in various conditions such as psoriasis, rheumatoid arthritis, and inflammatory bowel disease. This chapter provides a comprehensive overview of the molecular mechanisms underlying IL-23-mediated inflammation and its role in the development of pain. Additionally, the therapeutic potential of IL-23 inhibition is examined, with a particular focus on immunotherapy, through the review of clinical data that supports the high efficacy of IL-23 blockade in reducing inflammation, alleviating symptoms, and improving patient outcomes. Targeting IL-23 is seen as a promising strategy for managing inflammatory diseases, providing an alternative to conventional therapies.</p>","PeriodicalId":14422,"journal":{"name":"International review of cell and molecular biology","volume":"401 ","pages":"225-245"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147981724","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Epigenetic regulation via histone modifications in ovarian cancer.","authors":"Junzui Li, Hao Huang","doi":"10.1016/bs.ircmb.2025.08.003","DOIUrl":"10.1016/bs.ircmb.2025.08.003","url":null,"abstract":"<p><p>Ovarian cancer is a highly heterogeneous and lethal gynecological malignancy, with its progression tightly regulated by both genetic and epigenetic mechanisms. Among the epigenetic regulators, histone modifications-including acetylation, methylation, phosphorylation, ubiquitination, and SUMOylation-have emerged as pivotal modulators of chromatin architecture and gene transcription. These post-translational modifications, governed by specific histone-modifying enzymes, shape the transcriptional landscape of tumor cells and influence key oncogenic processes such as cellular proliferation, invasion, stemness, DNA repair, and chemotherapy resistance. Dysregulation of enzymes such as histone acetyltransferases (HATs), deacetylases (HDACs), methyltransferases (HMTs), demethylases (HDMs), ubiquitin ligases, and SUMO ligases has been implicated in the pathogenesis of ovarian cancer and is associated with adverse clinical outcomes. Importantly, these modifications are reversible, rendering them tractable therapeutic targets. This review provides a comprehensive synthesis of the major classes of histone modifications and their biological functions in ovarian cancer, highlights recent insights into the interplay between different modifications (crosstalk), and evaluates ongoing therapeutic strategies that aim to reverse epigenetic dysregulation. By elucidating the complex epigenetic landscape, this review supports the development of next-generation diagnostic, prognostic, and therapeutic approaches in ovarian cancer.</p>","PeriodicalId":14422,"journal":{"name":"International review of cell and molecular biology","volume":"400 ","pages":"107-134"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147573780","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Hongsheng Ji, Tingtao Ye, Xiaorui Nie, Yuming Chen, Huiqin Li, Silu Chen, Yanping Xiao, Ming Shao, Tao Wang, Rui Zheng, Mulong Du
{"title":"Circulating biomarkers: Facilitating the diagnosis and treatment of cancer and other chronic diseases.","authors":"Hongsheng Ji, Tingtao Ye, Xiaorui Nie, Yuming Chen, Huiqin Li, Silu Chen, Yanping Xiao, Ming Shao, Tao Wang, Rui Zheng, Mulong Du","doi":"10.1016/bs.ircmb.2025.05.001","DOIUrl":"10.1016/bs.ircmb.2025.05.001","url":null,"abstract":"<p><p>Circulating biomarkers are considered powerful tools for early disease diagnosis due to their stability in body fluids and their sensitivity and specificity in disease monitoring. This review provides an overview of the biological functions and indications of circulating biomarkers in the diagnosis, treatment, and prognosis of cancer and other common chronic diseases. It emphasizes the interplay between environmental exposure, changes in circulating biomarkers, and the development of diseases. The chapter integrates the latest research advancements in the classification and molecular mechanisms of circulating biomarkers, their applications in the diagnosis of common chronic diseases, and their role in personalized treatment, aiming to provide a reference for researchers and clinicians in the relevant fields.</p>","PeriodicalId":14422,"journal":{"name":"International review of cell and molecular biology","volume":"399 ","pages":"145-184"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146257927","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Advances in nano biomaterials for biomedical engineering.","authors":"Poojan Chaniyara, Mohnish Gandhi, Dhruvesh Maiya, Tvarit Patel","doi":"10.1016/bs.ircmb.2026.04.001","DOIUrl":"https://doi.org/10.1016/bs.ircmb.2026.04.001","url":null,"abstract":"<p><p>Systemic toxicity and off target effects are some of the major drawbacks of traditional, broad-spectrum therapies. Nanotechnology effectively counters these by offering precise, targeted alternatives and hence, reshaping biomedical engineering, therapeutics, diagnostics and even tissue regeneration. We explore six key nano-biomaterial platforms that exemplify this technological revolution. Silk fibroin nano-patches with engineered exosomes help diabetic wounds heal by producing collagen. Hydrogel activated with nanoparticle form nanoadhesives that bond well with wet environments, such as surgical sites. Graphene-based neural interfaces are characterized by high electrical conductivity with low immunogenicity. Bioelectronic-hydrogel composites adapt tissue mechanics for better physiological sensing. The pH-responsive metal-organic frameworks show remarkable potential in cancer treatment enabling targeted drug delivery, reducing harm to surrounding healthy tissue, and magnetic nanoparticles coated in cancer cell membranes improve natural killer-cell therapies. Despite these remarkable advances, the challenge of transition from laboratories to clinics faces many hurdles. Demands for scalable manufacturing techniques, strategies to suppress undesirable immune reactions and passing through safety and regulatory standards are some of the major challenges in Nanotechnology. Collaborative approaches from interdisciplinary fields like material science, biology, engineering and clinics may present a positive outlook to these issues. Nanotechnology can offer promising precision medicine tailored to an individual's safety and dosage profiles, minimising off target interaction risks.</p>","PeriodicalId":14422,"journal":{"name":"International review of cell and molecular biology","volume":"405 ","pages":"47-110"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148316896","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Shreya Dave, Juni Banerjee, Shuvomoy Banerjee, Anand Krishna Tiwari
{"title":"Neurodiagnostic: Advances in diagnostic tools.","authors":"Shreya Dave, Juni Banerjee, Shuvomoy Banerjee, Anand Krishna Tiwari","doi":"10.1016/bs.ircmb.2025.12.001","DOIUrl":"https://doi.org/10.1016/bs.ircmb.2025.12.001","url":null,"abstract":"<p><p>Understanding the pathologies related to neurological issues, viz. Alzheimer's disease (AD), brain tumors, and multiple sclerosis (MS) are complex and still lack effective therapeutics. Management of the global health burden caused by the escalating cases of neurodegenerative diseases urgently requires early and precise diagnosis. While conventional diagnostic tools like X-ray, Computed Tomography (CT), and Electrophysiological Techniques still hold a crucial role in the field of neurodiagnosis, researchers and clinicians are searching for advancements and the development of cutting-edge tools to enhance diagnostic accuracy, early detection, and improved health outcomes. Some later developed tools like PET and fMRI have proven beneficial in diagnosing the structural and functional aspects of neurological pathologies. However, specific and differential diagnosis for different neurodegenerative diseases is critical. We discuss how Omics studies (including proteomics and genomics), Artificial Intelligence (AI), and Machine learning (ML) have further enhanced the advancements in the field of neurodiagnostics. Our chapter highlights the importance of identifying novel blood-based, cerebrospinal fluid (CSF) based biomarkers while giving emphasis to developing non-invasive biomarkers to uplift the field of neurodiagnosis. The chapter concludes that the importance of the development of advanced bioimaging, multi-omics studies, computational studies, and exploring futuristic technologies, including the development of biosensors, can pave the path for next-generation neurodiagnostic techniques.</p>","PeriodicalId":14422,"journal":{"name":"International review of cell and molecular biology","volume":"405 ","pages":"111-147"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148316945","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Blair V Landon, Jinny Huang, Ellie G Evangelopoulou, Valsamo Anagnostou, Jenna V Canzoniero
{"title":"Liquid biopsy approaches to capture minimal residual disease and therapy response in patients with early stage cancers.","authors":"Blair V Landon, Jinny Huang, Ellie G Evangelopoulou, Valsamo Anagnostou, Jenna V Canzoniero","doi":"10.1016/bs.ircmb.2024.12.002","DOIUrl":"10.1016/bs.ircmb.2024.12.002","url":null,"abstract":"<p><p>Liquid biopsies are emerging as promising approaches to capture minimal residual disease (MRD) and interpret the heterogeneity of pathological responses after neoadjuvant therapy for patients with early stage cancers. Minimally invasive analyses of circulating cell-free tumor DNA (ctDNA) are enabled by advances in next generation sequencing and bioinformatic methodologies, resulting in sensitive and specific ctDNA detection. Emerging data supports the clinical utility of ctDNA status at different timepoints during the treatment trajectory and ctDNA MRD has been shown to predict clinical outcomes. Herein, we critically review ctDNA technologies and their analytical performance together with an assessment of the clinical sensitivity of these approaches to predict disease recurrence.</p>","PeriodicalId":14422,"journal":{"name":"International review of cell and molecular biology","volume":"399 ","pages":"113-143"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146258106","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Unraveling the interplay of glycolysis, lactylation, and autophagy.","authors":"Marco Cordani, Federica Michetti, Raffaele Strippoli, Cristiano Rumio, Guillermo Velasco, Fabrizio Marcucci","doi":"10.1016/bs.ircmb.2025.08.007","DOIUrl":"10.1016/bs.ircmb.2025.08.007","url":null,"abstract":"<p><p>Glycolysis and macroautophagy (hereafter autophagy) are fundamental biological processes involved in many physiological and pathological settings. Both have been shown to play pivotal roles in tumor initiation and progression. Metabolic reprogramming has been proposed as one of the hallmarks of cancer although in recent times the role of oxidative metabolism in tumorigenesis has been reevaluated and it seems more appropriate to talk about upregulated glycolytic or oxidative metabolism. Autophagy on the other hand, has been shown to play an antitumor role in initial stages of tumorigenesis, while having a tumor-promoting role in tumor progression. Glycolysis and autophagy have long been known to have a complex relationship with each other. In this article we give a picture of this relationship. We show that glycolysis can promote either upregulation or inhibition of autophagy. Vice versa, autophagy can also either promote upregulation or inhibition of glycolytic metabolism. These are highly contradictory effects that appear difficult to reconcile. We suggest that induction of glycolysis or autophagy in the presence of nutrient deprivation or nutrient sufficiency may be at the origin of at least part of these contradictory findings.</p>","PeriodicalId":14422,"journal":{"name":"International review of cell and molecular biology","volume":"403 ","pages":"29-63"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148217534","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Advances in protein engineering.","authors":"Huong Lan Vuong, Hien Thi Thu Le","doi":"10.1016/bs.ircmb.2025.11.002","DOIUrl":"10.1016/bs.ircmb.2025.11.002","url":null,"abstract":"<p><p>Protein engineering (PE) has been applied to various medicines, food, and environments. Contributions of proteins have been reported with remarkable results in protein therapeutics, antibody engineering, enzyme synthesis, and more specific functions in industrial processes. Therefore, this chapter highlights the most recent PE advances in a battle against mainly human diseases and biomedical sciences. The application of PE will be reviewed, focusing on developing innovative techniques, including evolution, rational design, semi-rational design, and hybrid approaches to protein design in applications. In addition, we provide key achievements of PE in CRISPR/Cas systems, high-through data, and synthetic biology with updated results. Current challenges of using PE, ethical considerations, and various approaches for protein therapeutics are also discussed. In this chapter, the updated findings provide a comprehensive overview of the transformative potential of PE for researchers in the application areas of human disease, especially in cancer therapeutics.</p>","PeriodicalId":14422,"journal":{"name":"International review of cell and molecular biology","volume":"402 ","pages":"61-87"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148030558","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Autophagy and type 2 diabetes: Bridging the gap in metabolic health.","authors":"Agustina Creus, Leonardo Ortega, David Sebastián","doi":"10.1016/bs.ircmb.2025.08.006","DOIUrl":"10.1016/bs.ircmb.2025.08.006","url":null,"abstract":"<p><p>Autophagy is a catabolic process key in the maintenance of cellular homeostasis in response to intracellular stress, and able to sense and transmit metabolic changes within tissues. Therefore, autophagy has emerged as a key process for metabolic homeostasis at whole body level. In this regard, alterations in autophagy are associated with the development of metabolic diseases, such as type 2 diabetes (T2D). Impairment in autophagy in metabolically relevant tissues including liver, muscle, adipose tissue and pancreatic β-cells, results in a further aggravation of diabetes-related metabolic alterations. This Review offers a comprehensive overview of our current understanding of autophagy and its role in the pathophysiology of T2D. Importantly, due to the relevance of autophagy in the development of T2D, we also summarize recent advancements in interventions and therapies targeting autophagy, providing insights into its therapeutic potential to combat this disease.</p>","PeriodicalId":14422,"journal":{"name":"International review of cell and molecular biology","volume":"403 ","pages":"65-83"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148217359","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}